Smith & Nephew (SNNUF) Cash from Financing Activities (2009 - 2024)
Smith & Nephew (SNNUF) reported Cash from Financing Activities of $372.0 million for Q4 2024, up 532.56% on a YoY basis from $58.8 million in Q1 2024, and up 532.56% quarter-over-quarter from -$86.0 million in Q4 2023.
Smith & Nephew (SNNUF) Cash from Financing Activities (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Cash from Financing Activities for 16 years, with the latest figure at $372.0 million in Q4 2024.
- For the quarter ending Q4 2024, Cash from Financing Activities rose 532.56% year-over-year to $372.0 million; the trailing twelve-month figure through Dec 2024 stood at -$720.0 million (up 6.13% YoY), and the FY2025 full-year result was -$955.0 million, down 1010.47% from the prior year.
- Cash from Financing Activities for Q4 2024 stood at $372.0 million, up from -$86.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $372.0 million in Q4 2024, with the low at -$704.0 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$79.0 million across 5 years, with a median of -$86.0 million in 2023.
- Annual changes were most pronounced in 2021 — Cash from Financing Activities slumped 192.92% — and 2024, when it jumped 532.56%.
- Smith & Nephew's Cash from Financing Activities stood at $325.0 million in 2020, then tumbled by 192.92% to -$302.0 million in 2021, then sank by 133.11% to -$704.0 million in 2022, then surged by 87.78% to -$86.0 million in 2023, then jumped by 532.56% to $372.0 million in 2024.
- The last three Cash from Financing Activities figures came in at $372.0 million (Q4 2024), -$86.0 million (Q4 2023), and -$704.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 372.00 Mn |
| Dec 31, 2024 | 372.00 Mn |
| Dec 31, 2023 | -86.00 Mn |
| Dec 31, 2023 | -86.00 Mn |
| Dec 31, 2022 | -704.00 Mn |
| Dec 31, 2022 | -704.00 Mn |
| Dec 31, 2021 | -302.00 Mn |
| Dec 31, 2021 | -302.00 Mn |
| Dec 31, 2020 | 325.00 Mn |
| Dec 31, 2020 | 325.00 Mn |
| Dec 31, 2019 | 303.00 Mn |
| Dec 31, 2019 | 303.00 Mn |
| Dec 31, 2018 | -371.00 Mn |
| Dec 31, 2018 | -371.00 Mn |
| Dec 31, 2017 | -434.00 Mn |
| Dec 31, 2017 | -434.00 Mn |
| Dec 31, 2016 | -529.00 Mn |
| Dec 31, 2016 | -529.00 Mn |
| Dec 31, 2015 | -558.00 Mn |
| Dec 31, 2015 | -558.00 Mn |